why choose us

First received: August 09, 2023

Clinical Trial: Phase 1 Study to Assess Safety and Efficacy of ANG003

Study Status: Completed

Recruit Status: RECRUITING

Condition: Exocrine Pancreatic Insufficiency

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Open-Label, Multicenter Study to Assess the Safety and Efficacy of ANG003 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Brief Summary: Randomized, parallel, active-treatment Phase 1 study of a single dose of orally administered ANG003 with a test meal in adult subjects with cystic fibrosis-related exocrine pancreatic insufficiency.The study's overall objectives are to evaluate the safety, tolerability and effect of four dose levels of ANG003.

Read more